Cumulative life course impairment: evidence for psoriasis.
Mattei, Peter L, Kristen C Corey, and Alexa B Kimball. 2013. “Cumulative Life Course Impairment: Evidence for Psoriasis.”. Current Problems in Dermatology 44: 82-90.
Search
Search results
717 results found
Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR).
Strober, Bruce, Melinda Gooderham, Elke M G J de Jong, Alexa B Kimball, Richard G Langley, Nikita Lakdawala, Kavitha Goyal, et al. 2018. “Depressive Symptoms, Depression, and the Effect of Biologic Therapy Among Patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR).”. Journal of the American Academy of Dermatology 78 (1): 70-80.
Psoriasis and latitude: Analytic approaches and future data needs.
Hartman, Rebecca I, and Alexa B Kimball. 2017. “Psoriasis and Latitude: Analytic Approaches and Future Data Needs.”. Journal of the American Academy of Dermatology 77 (2): e59.
Psoriasis - The Life Course Approach.
Linder, Michael Dennis, Stefano Piaserico, Matthias Augustin, Anna Belloni Fortina, Arnon D Cohen, Uwe Gieler, Gregor B E Jemec, et al. 2016. “Psoriasis - The Life Course Approach.”. Acta Dermato-Venereologica 96 (217): 102-8.
Cohort study of malignancies and hospitalized infectious events in treated and untreated patients with psoriasis and a general population in the United States.
Kimball, A B, J Schenfeld, N A Accortt, M S Anthony, K J Rothman, and D Pariser. 2015. “Cohort Study of Malignancies and Hospitalized Infectious Events in Treated and Untreated Patients With Psoriasis and a General Population in the United States.”. The British Journal of Dermatology 173 (5): 1183-90.
Psoriasis severity: commonly used clinical thresholds may not adequately convey patient impact.
Golbari, N M, J M van der Walt, A Blauvelt, C Ryan, P van de Kerkhof, and A B Kimball. 2021. “Psoriasis Severity: Commonly Used Clinical Thresholds May Not Adequately Convey Patient Impact.”. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (2): 417-21.
Treatment of psoriasis in pregnancy.
Flood, Kelsey S, Kevin T Savage, Martina L Porter, and Alexa B Kimball. 2020. “Treatment of Psoriasis in Pregnancy.”. Cutis 106 (2S): 15-20.
Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council.
Strober, Bruce, Caitriona Ryan, Peter van de Kerkhof, Joelle van der Walt, Alexa B Kimball, Jonathan Barker, Andrew Blauvelt, and International Psoriasis Council Board Members and Councilors. 2020. “Recategorization of Psoriasis Severity: Delphi Consensus from the International Psoriasis Council.”. Journal of the American Academy of Dermatology 82 (1): 117-22.
Safety of guselkumab in patients with moderate-to-severe psoriasis treated through 100 weeks: a pooled analysis from the randomized VOYAGE 1 and VOYAGE 2 studies.
Reich, K, K A Papp, A W Armstrong, Y Wasfi, S Li, Y K Shen, B Randazzo, M Song, and A B Kimball. 2019. “Safety of Guselkumab in Patients With Moderate-to-Severe Psoriasis Treated through 100 Weeks: A Pooled Analysis from the Randomized VOYAGE 1 and VOYAGE 2 Studies.”. The British Journal of Dermatology 180 (5): 1039-49.
Clinical Goals and Barriers to Effective Psoriasis Care.
Strober, Bruce E, Joelle M van der Walt, April W Armstrong, Marc Bourcier, Andre E Carvalho V, Edgardo Chouela, Arnon D Cohen, et al. 2019. “Clinical Goals and Barriers to Effective Psoriasis Care.”. Dermatology and Therapy 9 (1): 5-18.